| Multiple Sclerosis |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Immunotherapy |
0 |
0.99 |
| Antineoplastic Drug |
0 |
0.49 |
| Monoclonal Antibody |
0 |
0.49 |
| Care and Maintenance of Vision |
0 |
0.35 |
| Child |
0 |
0.29 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.27 |
| Hospital |
0 |
0.2 |
| Immunoglobulin A (IgA) |
0 |
0.2 |
| Massachusetts |
0 |
0.2 |
| Acute Disseminated Encephalomyelitis |
0 |
0.1 |
| Immunosuppressive Therapy |
0 |
0.1 |
| Intravenous |
0 |
0.1 |
| Myelin |
0 |
0.1 |
| Optic Neuritis |
0 |
0.1 |
| Residency |
0 |
0.1 |
| Tolerance |
0 |
0.1 |
| Transverse Myelitis |
0 |
0.1 |